Microvi to Present Technology at American Chemical Society (ACS) National Meeting
April 3, 2017 – Microvi will make a presentation Tuesday at the American Chemical Society’s National Meeting & Exposition about the company’s groundbreaking dioxane removal technology.
The talk, entitled “Bioprocess development for 1,4-dioxane treatment: Bench through field investigation,” will be delivered by Microvi’s Director of Innovation Research Ameen Razavi. It explores the challenges of dioxane remediation, and how Microvi’s MB-DX technology provides a novel, cost-effective solution for its treatment.
Dioxane is classified as a carcinogen and various state, federal and international authorities have set regulatory limits ranging from 1-70 μg/L. It has been used around the world for decades in solvents, pesticides, resins, oils, adhesives and waxes. It remains recalcitrant for years and spreads rapidly through groundwater, causing a significant public health risk.
The American Chemical Society’s National Meeting & Exposition is being held April 2-6 in San Francisco. Microvi’s presentation will be held Tuesday, April 4 at 3:50 pm at the San Francisco Marriott Marquis, 780 Mission St.
About Microvi
Microvi is an applied biotechnology company based in the San Francisco Bay Area that develops and commercializes next-generation biosolutions to address critical challenges in climate change, water, energy, waste, health, and environmental sustainability. Powered by its proprietary MicroNiche Engineering™ (MNE) platform, Microvi delivers proven, high-performance biosolutions worldwide – reducing greenhouse gas emissions and waste while increasing productivity and cost-efficiency for its customers. Microvi’s scaleable biosolutions are deployed globally across diverse sectors, providing disruptive economic value for industry partners and ultimately contributing to a cleaner environment and healthier communities. Learn more at Microvi Biotech.
###
CONTACT:
Microvi Marketing
info@microvi.com
510-344-0668